Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 398

The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.

Cancer Chemopreventive Activity of Resveratrol

BHAT, KRISHNA P.L., PEZZUTO, JOHN M.·2002·Annals of the New York Academy of Sciences

Abstract

A bstract:Cancer chemopreventive agents are designed to reduce the incidence of tumorigenesis by intervening at one or more stages of carcinogenesis. Recently, resveratrol, a natural product found in the diet of humans, has been shown to function as a cancer chemopreventive agent. Resveratrol was first shown to act as an antioxidant and antimutagenic agent, thus acting as an anti‐initiation agent. Further evidence indicated that resveratrol selectively suppresses the transcriptional activation of cytochrome P‐450 1A1 and inhibits the formation of carcinogen‐induced preneoplastic lesions in a mouse mammary organ culture model. Resveratrol also inhibits the formation of 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA)‐promoted mouse skin tumors in the two‐stage model. The enzymatic activities of COX‐1 and ‐2 are inhibited by resveratrol in cell‐free models, and COX‐2 mRNA and TPA‐induced activation of protein kinase C and AP‐1‐mediated gene expression are suppressed by resveratrol in mammary epithelial cells. In addition, resveratrol strongly inhibits nitric oxide generation and inducible nitric oxide synthase protein expression. NFκB is strongly linked to inflammatory and immune responses and is associated with oncogenesis in certain models of cancer, and resveratrol suppresses the induction of this transcription factor by a number of agents. The mechanism may involve decreasing the phosphorylation and degradation of IκBα. At the cellular level, resveratrol also induces apoptosis, cell cycle delay or a block in the G 1→ S transition phase in a number of cell lines. Thus, resveratrol holds great promise for future development as a chemopreventive agent that may be useful for several disorders. Preclinical toxicity studies are underway that should be followed by human clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.2002.tb02918.x

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 104 references

Cited by

See all 398

Metadata

Authors
BHAT, K. P. L., & PEZZUTO, J. M.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2002-05
Volume
957
Issue
1
Pages
210-229
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W2121016657
Cited by
398
References
104
FWCI
12.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer Chemopreventive Activity of Resveratrol. https://app.cochat.ai/papers/10.1111/j.1749-6632.2002.tb02918.x
The paper
BHAT, K. P. L., & PEZZUTO, J. M. (2002). Cancer Chemopreventive Activity of Resveratrol. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2002.tb02918.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.